The ribosomal protein S12 (RPS12) is a component of the 40S subunit of eukaryotic ribosomes, playing a critical role in protein synthesis by ensuring translational accuracy and ribosome stability. As part of the small ribosomal subunit, RPS12 interacts with mRNA and tRNA during initiation and elongation phases, contributing to codon-anticodon recognition. Beyond its canonical role, emerging studies suggest RPS12 may have extraribosomal functions, including involvement in cell proliferation, apoptosis, and DNA damage response pathways.
Antibodies targeting RPS12 are valuable tools for investigating ribosome biogenesis, translational regulation, and disease mechanisms. They are widely used in techniques like Western blotting, immunofluorescence, and immunoprecipitation to study RPS12 expression, localization, and protein interactions. Dysregulation of RPS12 has been implicated in cancers (e.g., hepatocellular carcinoma, leukemia) and neurological disorders, with some studies highlighting its potential as a diagnostic or prognostic biomarker. Research also explores its role in viral infections, as certain viruses hijack ribosomal proteins for replication. Commercial RPS12 antibodies are typically raised against conserved epitopes, offering cross-reactivity across human, mouse, and rat samples. Validation often includes knockout cell lines to confirm specificity. Ongoing research continues to unravel RPS12's multifaceted roles in health and disease, driving demand for reliable antibodies in both basic and translational studies.